6505--Metformin HCL SA Tablets
Closed Pre-Solicitation Posted
- Solicitation number
- 36E79725Q0001
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA), Department of Defense (DOD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC) are conducting market research for the procurement of Metformin HCL SA Tablets. The resulting contract will be a national mandatory requirements contract. Key requirements include providing a unique National Drug Code (NDC) number, submitting a letter of commitment from the manufacturer, and having business-to-business agreements with pharmaceutical prime vendors. Responses to the market research questionnaire are due by October 17, 2024, and the contract is expected to start on July 1, 2025 when the current contract expires.
This procurement is not set-aside for any specific business size. The estimated annual usage is 14,500,400 tablets of 500mg Metformin HCL 24HR SA in 100-count bottles and 79,996,000 tablets in 500-count or 1,000-count bottles. For 750mg Metformin HCL 24HR SA, the estimated annual usage is 3,795,800 tablets in 100-count bottles and 1,211,000 tablets in 500-count or 1,000-count bottles. The VA's estimated annual usage is 216,034,583 tablets of 500mg and 8,380,599 tablets of 750mg.
Notice text
MARKET RESEARCH QUESTIONNAIRE Metformin HCL SA Tablets
Company Name: _________________________
I am conducting market research for the procurement of Metformin HCL SA Tabs for the Department of Veterans Affairs (VA), Department of Defense (DOD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore, it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate by group for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:
1. Is your Company able to meet the following minimum requirements:
National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All bottles of 400 tablets/capsules or less must have a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap child resistant closure. Does your company have a unique NDC (Labeler Code)?_____________
If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer:_________________
Would you be able to provide a letter of commitment from the manufacturer of the offered drug?_____________
Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and DOD acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Programs (PPVs). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders if an award is made. For this procurement, all VA ordering will be for Group 2, Bulk through the Repackaging Program and OGAs (Group 1) will be through the PPVs. Does your company currently have a business-to-business agreement with the PPVs?_________
d. Under NAICS code 325412, is your company size (check one):
Large Business ______
Small Business ______
e. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________
f. Is the offered end-product U.S-made or an end product of a Trade Agreements Act designated country?_________
g. All OGA (Other Government Agency) requirements will go through the PPVs. All VA requirements will be purchased in bulk and go through the Pharmaceutical Repackager (currently Aphena Pharma Solutions). Groups 1 & 2 may be awarded separately for a possibility of two awards. Can your company meet the following product, bottle size and usage:
Â
GROUP 1 - OGA
Â
Â
Â
ITEM
DESCRIPTION
PKG SIZE (BT)
TOTAL EST ANNUAL USAGE (BT)
TOTAL QTY (TAB)
1
METFORMIN HCL 500MG 24HR TAB,SA
100
145,004
14,500,400
2a
METFORMIN HCL 500MG 24HR TAB,SA
500
159,992
79,996,000
OR
OR
OR
OR
OR
2b
METFORMIN HCL 500MG 24HR TAB,SA
1000
79,996
79,996,000
3
METFORMIN HCL 750MG 24HR TAB,SA
100
37,958
3,795,800
4a
METFORMIN HCL 750MG 24HR TAB,SA
500
2,422
1,211,000
OR
OR
OR
OR
OR
4b
METFORMIN HCL 750MG 24HR TAB,SA
1000
1,211
1,211,000
GROUP 2 - VA
ITEM
VA REPACK PROGRAM ESTIMATES
Â
Â
QTY (Tabs) bulk
1
METFORMIN HCL 500MG 24HR TAB,SA
216,034,583
2
METFORMIN HCL 750MG 24HR TAB,SA
Â
Â
8,380,599
2 . Is your Company interested in submitting a response to a solicitation?________
3. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers continuity and consistency of product by allowing long term committed purchases of your product. If interested, please indicate Base year and how many Option periods, not to exceed 4._________________
4. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date (current contract expires 06/30/2025)?
______________________________________________________________________
5. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.
______________________________________________________________________
If you could provide your responses by next Thursday, October 17, 2024, it would be greatly appreciated. Please contact me if you have any questions.
Files
| File | Type | Posted |
|---|---|---|
| 36E79725Q0001_1.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity